Empresa TapImmune Inc. Other OTC
Acciones
US8760333091
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
30/04 | MARKER THERAPEUTICS, INC. : Ladenburg Thalmann da una recomendación de compra | ZM |
25/03 | Marker Therapeutics, Inc. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023 | CI |
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Immunotherapies and Innovative Peptide-Based Vaccines
100,0
%
| 9 | 100,0 % | 3 | 100,0 % | -63,26 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 9 | 100,0 % | 3 | 100,0 % | -63,26 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Juan Vera
CEO | Chief Executive Officer | 44 | 17/10/18 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/11/19 |
Chief Tech/Sci/R&D Officer | 51 | 23/10/18 | |
Chief Administrative Officer | - | 01/09/15 | |
John Wilson
BRD | Director/Board Member | 64 | - |
Edmund Cheung
HRO | Human Resources Officer | - | 01/01/21 |
Nadia Agopyan
LAW | General Counsel | 62 | 15/08/19 |
General Counsel | 67 | 23/10/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Norman Eansor
CHM | Chairman | 63 | 17/10/18 |
Steven Elms
BRD | Director/Board Member | 60 | 06/08/19 |
Katharine Knobil
BRD | Director/Board Member | 60 | 08/12/21 |
John Wilson
BRD | Director/Board Member | 64 | - |
Juan Vera
CEO | Chief Executive Officer | 44 | 17/10/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 8 913 490 | 7 825 038 ( 87,79 %) | 0 | 87,79 % |
Información de la empresa
Marker Therapeutics, Inc.
4551 Kennedy Commerce Drive
77032, Houston
+713 400 6400
http://www.markertherapeutics.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+33,37 % | 49,46 mil M | |
+1,55 % | 42,58 mil M | |
+49,11 % | 42,49 mil M | |
-4,22 % | 29,09 mil M | |
+11,57 % | 26,61 mil M | |
-21,00 % | 18,64 mil M | |
+7,36 % | 13,16 mil M | |
+28,30 % | 12,55 mil M | |
+23,80 % | 12,1 mil M |
- Bolsa de valores
- Acciones
- Acción MRKR
- Acción
- Empresa TapImmune Inc.